Next Article in Journal
Effect of Resveratrol-Enriched Rice on Skin Inflammation and Pruritus in the NC/Nga Mouse Model of Atopic Dermatitis
Next Article in Special Issue
Targeting the ERK Signaling Pathway in Melanoma
Previous Article in Journal
Two-Dimensional and Three-Dimensional Single Particle Tracking of Upconverting Nanoparticles in Living Cells
Previous Article in Special Issue
Roles of Cyclic AMP Response Element Binding Activation in the ERK1/2 and p38 MAPK Signalling Pathway in Central Nervous System, Cardiovascular System, Osteoclast Differentiation and Mucin and Cytokine Production
Review

Impact of ERK5 on the Hallmarks of Cancer

1
Tumor Cell Biology Unit–Core Research Laboratory, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), V. le Pieraccini 6, 50139 Florence, Italy
2
Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Viale G. B. Morgagni 50, 50134 Florence, Italy
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(6), 1426; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20061426
Received: 31 January 2019 / Revised: 15 March 2019 / Accepted: 18 March 2019 / Published: 21 March 2019
(This article belongs to the Special Issue ERK Signaling Pathway in Diseases)
Extracellular signal-regulated kinase 5 (ERK5) belongs to the mitogen-activated protein kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic cells and elicits several biological responses, including cell survival, proliferation, migration, and differentiation. In recent years, accumulating lines of evidence point to a relevant role of ERK5 in the onset and progression of several types of cancer. In particular, it has been reported that ERK5 is a key signaling molecule involved in almost all the biological features of cancer cells so that its targeting is emerging as a promising strategy to suppress tumor growth and spreading. Based on that, in this review, we pinpoint the hallmark-specific role of ERK5 in cancer in order to identify biological features that will potentially benefit from ERK5 targeting. View Full-Text
Keywords: ERK5; BMK1; MAPK7; MEK5; cancer; cell proliferation; invasion; metastasis; apoptosis; targeted therapy ERK5; BMK1; MAPK7; MEK5; cancer; cell proliferation; invasion; metastasis; apoptosis; targeted therapy
Show Figures

Figure 1

MDPI and ACS Style

Stecca, B.; Rovida, E. Impact of ERK5 on the Hallmarks of Cancer. Int. J. Mol. Sci. 2019, 20, 1426. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20061426

AMA Style

Stecca B, Rovida E. Impact of ERK5 on the Hallmarks of Cancer. International Journal of Molecular Sciences. 2019; 20(6):1426. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20061426

Chicago/Turabian Style

Stecca, Barbara, and Elisabetta Rovida. 2019. "Impact of ERK5 on the Hallmarks of Cancer" International Journal of Molecular Sciences 20, no. 6: 1426. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20061426

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop